Live

Medtronic plc. Ordinary Shares (MDT) congressional disclosures

Healthcare · coverage Jan 12, 2024–Sep 1, 2026

Email me the next MDT filing — free
Tracked disclosures
29
Lawmakers
13
Reported purchase / sale rows
11 / 18A disclosure count, not congressional market sentiment

Estimated market comparison · not an official filing fact

Available with Pro

Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.

Disclosure alert preview

Based on a real public filing

Sale

Kevin Hern

MDTMedtronic plc. Ordinary Shares

$15K - $50K

Traded
Aug 24, 2026
Filed
Sep 1, 2026
Disclosure delay
8 days
Reported owner
Joint

This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Sep 28, 2026.

Official filing

MDT congressional trades snapshot

This page summarizes public STOCK Act disclosures involving MDT. It is useful for seeing which lawmakers reported MDT transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Sep 1, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the MDT congressional trade page shows

Congressional Trader tracks 29 public STOCK Act disclosures for MDTacross 13 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent MDT filing shown here was filed on Sep 1, 2026 by Kevin Hern as a sale. Related lawmakers include Kathy E. Manning, Jared Moskowitz, John James, Richard McCormick, Robert P. Bresnahan.

FAQ

Which lawmakers traded MDT?

Recent MDT disclosures include Kathy E. Manning, Jared Moskowitz, John James, Richard McCormick, Robert P. Bresnahan.

What is the buy/sell mix for MDT?

The visible sample currently shows 11 purchases and 18 sales or partial sales.

Should I trade based on MDT disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.